Key result
Renal resistive index evaluated by Doppler ultrasonography serves as a multifunctional tool to estimate cardiovascular and renal risk and guide therapeutic decisions in hypertensive patients.
Why the study?
Does renal resistive index evaluation help in cardiovascular risk evaluation and therapeutic decisions in hypertensive patients?
Does renal resistive index evaluation help in cardiovascular risk evaluation and therapeutic decisions in hypertensive patients?
Renal resistive index measured by Doppler ultrasound is a useful noninvasive tool for evaluating cardiovascular and renal risk in hypertensive patients.
Supports RRI for hypertension risk stratification; leaves open therapeutic impact pending prospective validation.
Spectral Doppler ultrasonography provides the evaluation of renal resistive index (RRI), a noninvasive and reproducible measure to investigate arterial compliance and/or resistance. RRI seems to possess an important role in the evaluation of diverse cases of secondary hypertension. In essential hypertension, RRI is associated with subclinical markers of target organ damage and reflects renal disease progression beyond albuminuria and creatinine clearance. Also, RRI can estimate cardiovascular and renal risk. The evaluation of RRI may also help the therapeutic decisions. Given its simple assessment, RRI emerges as a simple method and a "multifunctional" tool that could help on the cardiovascular risk evaluation of the hypertensive patient.
No takes yet. Share an insight, caveat, or question.
Andrikou et al. (2018) conducted a review in Hypertension. Renal resistive index (RRI) evaluation was evaluated. Renal resistive index evaluated by Doppler ultrasonography serves as a multifunctional tool to estimate cardiovascular and renal risk and guide therapeutic decisions in hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: